VISCHER acted as legal advisor to LimmaTech Biologics in the transaction.LimmaTech Biologics AG closed a USD 37m (CHF 33m) Series A financing round co-led by Adjuvant Capital,…
VISCHER acted as legal advisor to LimmaTech Biologics in the transaction.LimmaTech Biologics AG closed a USD 37m (CHF 33m) Series A financing round co-led by Adjuvant Capital,…
You must be a Standard 1 Year member to access this content.
…
You must be a Standard 1 Year member to access this content.